to an agent like clozapine might be prophylactic. The latter agent has been shown to have minimal central antidopaminergic effects? and would therefore be expected to produce much fewer extrapyramidal side-effects.
Hairy cell leukaemia (HCL) is a chronic form of leukaemia that predominantly affects middle aged men. Neurological complications have been reported in only 5% of patients, mainly due to infections! or leukaemic infiltration" of the central nervous system. We describe a patient with Guillain-Barre syndrome (GBS) associated with HCL which, to our knowledge, has not been described in the literature.
Case report
A 78-year-old retired miner was admitted with a 2-week history of progressive weakness of limbs, constipation and retention of urine. There was no preceding history of viral illness. He was on captopril 25 mg twice daily and hydrochlorothiazide 5 mg daily for hypertension. On examination he was heavily built, apyrexial and had a blood pressure of 170/85 mmHg. Cardiovascular, respiratory and abdominal examination were all normal. Neurological examination revealed higher functions and cranial nerves to be unaffected. Muscular fasciculations were present in all limbs, with power grade 3/5 proximally and 4/5 distally. There was generalized areflexia and both plantars were equivocal. Sensation was intact.
Laboratory data: haemoglobin 14.1 g/dl, whole blood count 10.2x10 9 /L with lymphocytes 4.78x10 9 /L, platelets 216 x 10 9 /L, erythrocyte sedimentation rate 10 mmlh and peripheral blood smear showed abnormal mononuclear cells. Biochemical results showed plasma sodium 121 mmol/l, potassium 3.05 mmol/l, urea, creatinine and glucose were normal. The CSF was clear, sterile with normal cell counts and a protein level of 1.1 gil and IgG of 0.1 gil. Monospot test was negative, viral titres were insignificant and blood culture sterile. Bone marrow examination showed malignant lymphoproliferative morphology suggestive of hairy cell leukaemia. Whole blood count cell markers in the peripheral blood confirmed B cell monoclonal proliferation (CD22· activated B cells 96%, CD19-pre B cells 71% and lambda 80%) and a reactive T cell subpopulation (CD4-0KT4 24% and CD8·0KT8 4%). Electromyography and nerve conduction studies were reported as showing severe motor and sensory peripheral neuropathy with predominant demyelination and a degree of secondary axonal degeneration.
Treatment was commenced with subcutaneous interferon 3 million IV three times a week for 2 weeks and intravenous methylprednisolone 500 mg daily for 3 days. The illness was complicated by deep vein thrombosis, multiple pulmonary emboli and supraventricular tachycardia. The patient died of progressive respiratory failure 4 weeks after admission.
Postmortem examination confirmed the diagnosis of GBS. The inflammatory infiltrate was predominantly perivascular in an epineural and extrafascicular distribution and showed a heterogeneous mixture of mononuclear inflammatory cells. Immunoperoxidase studies for immunoglobulin light chains showed a polyclonal staining pattern. There was no evidence of direct leukaemia/lymphomatous infiltration on the nerves.
Discussion
Both GBS and HCL are very uncommon diseases making a chance association unlikely. Cases of GBS may have an underlying cause other than previous viral infection; for example Hodgkin's disease, neoplasms, metabolic disease and a variety of endocrine conditions''. However, GBS has not been reported previously either as the presenting feature or as a complication of HCL.
GBS is an immunologically-mediated disease caused by a delayed hypersensitivity reaction provoked, in a manner not yet understood, by antecedent viral infection or other conditions. Under certain circumstances, partial and perhaps transient immunosuppression could serve as one contributing factor in triggering GBS4.
In a proportion of patients with GBS alterations in peripheral blood lymphocyte subpopulations have been descrfbed". These include an increased helper/suppressor T-cell ratio due to a reduction in the OKT8 (suppressor cells) subpopulation. B cell and OKT4 (helper cells) populations remained normal. In our patient there was a predominant neoplastic B cell population. The reactive T cell population showed a helper/suppressor ratio of 6 : 1 (normal 2 : 1) due to loss of OKT8 cells. Thus depression of these OKT8 cells in GBS might permit the development of autoimmunity to myelin antigens and so play an important role in pathogenesis. The mechanism whereby HCL was associated with this abnormal T-helper and suppressor cells ratio is not clear. However it is likely that the development of GBS in this patient reflects an effect ofHCL upon the immune status of the patient.
A syndrome of obesity, short stature, cryptorchidism and mental retardation with hypotonia in the neonatal period was first described by Prader, Labhart and Willi in 1956 1 • It is a rare syndrome (l in 15000 live births)", but in the last 4 years the author has witnessed anaesthesia in two cases.
Case reports Case 1
A 2-year-oldboy presented for correction of ventral curvature of micropenis. He also had cryptorchidism; the syndrome had been suspected soon after birth because of hypotonia and poor feeding, even now the child only weighed 10 kg.
Premedication comprised trimeprazine 15 mg, plus parenteral morphine 2.5 mg with glycopyrrolate 50 p.g. Fasting glucose was 7.5-9 mmolll. An inhalational induction was performed without difficulty using halothane. Laryngoscopy was normal and atracurium 5 mg was used to facilitate intubation. Isoflurane 0.5-1 % in nitrous oxide and oxygen was used to maintain anaesthesia.
A caudal epidural was performed to provide postoperative analgesia and residual neuromuscular blockade was promptly antagonized with neostigmine and glycopyrrolate. Blood glucose remained at 7.5-9 mmolll, and subsequent progress was uneventful.
Case 2
The second case took place at another teaching hospital in 1985; he was aged 18 but had a mental age ofG and weighed 212 kg. His thighs were so bulky that walking necessitated circumduction of each leg, also sitting down to attend to personal hygiene had become difficult. It was proposed to remove some of this excess tissue from one thigh.
Day-time solemnence was not present, but sleep was attended by continuous snoring. Right bundle-branch block was present on the electrocardiogram, and haematocrit was normal.
Premedication consisted of intramuscular papaveretum 20 mg and scopolamine 0.4 mg. Anaesthesia was conducted by the consultant who had dealt with the patient 2 years previously for a similar procedure, and elected again to use halothane in nitrous oxide and oxygen for induction with maintenance of anaesthesia breathing spontaneously. Laryngoscopy was not attempted.
Postoperatively, emergence was slow and accompanied by snoring. Although no complications were documented, wound healing and mobilization were slow.
Discussion
A partial deletion of chromosome 15 is a marker for the Prader-Willi syndrome (PWS)3. The associated hypogonadism suggests a hypothalamic lesion.
During phase I infants characteristically suckle poorly and prolonged nasogastric feeding may be necessary, the cough reflex is weak and episodes of asphyxia may occur.
Phase II begins at 3-5 years of age when hyperphagia ensues and extreme obesity develops.
Other features include acromicria with micropenis, micrognathia, high-arched palate, scoliosis and dislocation of the hip. Cardiac conduction defects have been noted and convulsions are common in those with PWS. A reduced tendency to vomit is attributed to the hypothalamic lesiorr'.
Glucose intolerance or frank diabetes are found in obese individuals' and both hypothermia and hyperthermia have been reported in response to operative stress5.6. No cases of PWS have been referred for investigation at Leedsmalignant hyperpyrexia centre (Ellis FR, personal communication) so the relationship to malignant hyperpyrexia remains uncertain. Muscle biopsy has revealed fatty infiltration of type II (fast-twitch) fibres", which may account for the hypotonia, but contacture tests have not been reported.
Patients present for anaesthesia to undergo orchidopexy, orthopaedic surgery, dental surgery, squint correction, cleft lip and palate repair or surgery for obesity later in life". Life expectancy can now reach the fifth decade if extreme obesity is avoided.
Therefore careful assessment, attention to glycaemic control and body temperature, combined with judicious use of muscle relaxants in phase I of the condition, with measures to reduce risks due to the obesity characteristic of phase II are likely to result in an uneventful outcome following anaesthesia in Prader-Willi syndromev",
